LONDON (Reuters) - U.S. drugmaker Merck and German diagnostics firm Qiagen are donating millions of human papillomaviros (HPV) vaccines and 250,000 HPV tests to Rwanda to start a national cervical cancer prevention program.
Source: http://feeds.reuters.com/~r/reuters/healthNews/~3/2cJvsCoN8M0/us-merck-qiagen-rwanda-idUSTRE73O33320110425
Critical Care Dental Care Depression Detoxification Developmental Disabilities Diabetes
No comments:
Post a Comment